AdAlta Ltd. | Income Statement

Fiscal year is July-June. All values AUD Thousands.
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
0.70
0.70
5.40
3.10
Gross Income
0.70
0.70
5.40
3.10
SG&A Expense
2,207.50
1,909.30
4,794.80
5,879.00
EBIT
-
1,910.00
4,800.20
5,882.10
Non Operating Income/Expense
0.40
-
-
52.80
Pretax Income
2,186.30
1,901.10
4,609.50
5,875.10
Income Tax
878.40
738.00
1,777.00
2,020.20
Consolidated Net Income
1,307.90
1,163.10
2,832.50
3,854.90
Net Income
1,307.90
1,163.10
2,832.50
3,854.90
Net Income After Extraordinaries
1,307.90
1,163.10
2,832.50
3,854.90
Net Income Available to Common
1,307.90
1,163.10
2,832.50
3,854.90
EPS (Basic)
0.01
0.01
0.03
0.04
Basic Shares Outstanding
100,000.00
100,000.00
90,035.60
101,287.30
EPS (Diluted)
0.01
0.01
0.03
0.04
Diluted Shares Outstanding
100,000.00
100,000.00
90,035.60
101,287.30
EBITDA
2,207.50
1,909.30
4,794.80
5,879.00
Non-Operating Interest Income
12.80
8.90
170.90
59.80

About AdAlta

View Profile
Address
2 Park Drive
Bundoora Victoria (VIC) 3083
Australia
Employees -
Website http://www.adalta.com.au
Updated 07/08/2019
AdAlta Ltd. operates as a biotechnology company, discovers, develops, and commercializes protein based therapeutics. The company was founded in 2007 and is headquartered in Bundoora, Australia. .